MedPath

B40 Non-Invasive Blood Pressure Equivalency Study

Not Applicable
Completed
Conditions
Blood Pressure
Interventions
Device: Blood Pressure Readings on B40 Patient Monitor
Registration Number
NCT01546285
Lead Sponsor
GE Healthcare
Brief Summary

The purpose of this study is to demonstrate equivalency of the GE Healthcare B40 Patient Monitor noninvasive blood pressure (NIBP) parameter compared to the reference device.

Detailed Description

Automated non-invasive blood pressure devices have a long history. These devices first made their appearance in the mid-1970's. Since that time, there have been many improvements in the performance of these devices. Specifically, when making changes to the algorithms that control these devices, the goals are: to improve accuracy and precision in the blood pressure (BP) estimates, to reduce the time needed to determine the BP estimates, to increase comfort for the patient, and to work through artifacts and arrhythmias that are often present in the clinical environment.

The purpose of this study is to demonstrate equivalency of the GE Healthcare B40 Patient Monitor noninvasive blood pressure (NIBP) parameter compared to the reference device.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
66
Inclusion Criteria
  • Ability to provide written informed consent or have a legally authorized representative including a parent or guardian provide written informed consent
  • Within the age range from older than 3 years old to 75 years old (adult and child)
  • Ability to maintain proper placement of cuff and/or probe and/or sensor
Exclusion Criteria
  • Neonates (ages 0-29 days) and infants (30 days to 3 years old) shall be excluded
  • Any subject deemed too unstable, by clinician's discretion, or for another reason deemed unacceptable for study by the clinician
  • Known dysrhythmias (when applicable)
  • Known disease state that compromises circulation to the extremity
  • Vigorous exercise prior to participating in the study
  • Excessive movement or excitability causing false values or no determinations
  • Known allergy to latex when latex products will be in contact with subject
  • Pregnant females

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Blood Pressure ReadingBlood Pressure Readings on B40 Patient MonitorSimultaneous blood pressure readings with DINAMAP PRO1000 and B40 monitor; total of 6 successful readings
Primary Outcome Measures
NameTimeMethod
Difference Between the B40 Monitor and Reference Device DINAMAP PRO1000 on NIBP MeasurementsEnd of each blood pressure reading

The primary endpoints are the difference in systolic, diastolic and mean blood pressure values between the B40 Monitor and PRO1000. The mean of the difference should be no more than 5mmHg and the standard deviation of the difference should be no more than 8mmHg per the AAMI SP-10 standard.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinimark

🇺🇸

Louisville, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath